Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Eltrombopag for patients with moderate aplastic anemia or uni-lineage cytopenias
Xing Fan, Ronan Desmond, Thomas Winkler, et al.
Blood Advances (2020) Vol. 4, Iss. 8, pp. 1700-1710
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

NCCN Guidelines® Insights: Myelodysplastic Syndromes, Version 3.2022
Peter L. Greenberg, Richard M. Stone, Aref Al‐Kali, et al.
Journal of the National Comprehensive Cancer Network (2022) Vol. 20, Iss. 2, pp. 106-117
Open Access | Times Cited: 96
Guidelines for the diagnosis and management of adult aplastic anaemia: A British Society for Haematology Guideline
Austin Kulasekararaj, Jamie Cavenagh, Inderjeet Dokal, et al.
British Journal of Haematology (2024) Vol. 204, Iss. 3, pp. 784-804
Open Access | Times Cited: 35
Acquired severe aplastic anaemia: how medical therapy evolved in the 20th and 21st centuries
Phillip Scheinberg
British Journal of Haematology (2021) Vol. 194, Iss. 6, pp. 954-969
Open Access | Times Cited: 57
Current evidence and the emerging role of eltrombopag in severe aplastic anemia
Beatrice Drexler, Jakob Passweg
Therapeutic Advances in Hematology (2021) Vol. 12, pp. 204062072199812-204062072199812
Open Access | Times Cited: 33
Deciphering treatment patterns in non-severe/moderate aplastic anemia: an international observational study
Bruno Fattizzo, Carmelo Gurnari, Giulio Cassanello, et al.
Leukemia (2023) Vol. 37, Iss. 12, pp. 2479-2485
Open Access | Times Cited: 11
Efficacy of JAK1/2 inhibition in murine immune bone marrow failure
Emma M. Groarke, Xingmin Feng, Nidhi Aggarwal, et al.
Blood (2022) Vol. 141, Iss. 1, pp. 72-89
Open Access | Times Cited: 18
Eltrombopag in children with severe aplastic anemia
Harry Lesmana, Timothy W. Jacobs, Michelle Boals, et al.
Pediatric Blood & Cancer (2021) Vol. 68, Iss. 8
Closed Access | Times Cited: 23
Immunosuppressive therapy in severe aplastic anemia
Bhavisha A. Patel, Danielle M. Townsley, Phillip Scheinberg
Seminars in Hematology (2022) Vol. 59, Iss. 1, pp. 21-29
Closed Access | Times Cited: 15
Ongoing production of tissue-resident macrophages from hematopoietic stem cells in healthy adult macaques
Andrew R. Rahmberg, Chuanfeng Wu, Tae–Hoon Shin, et al.
Blood Advances (2023) Vol. 8, Iss. 3, pp. 523-537
Open Access | Times Cited: 9
Avatrombopag, a promising novel thrombopoietin receptor agonist for refractory/relapsed/intolerant non-severe aplastic anemia: a phase 2 single-arm clinical trial
Ziqi Wan, Miao Chen, Bing Han
Annals of Medicine (2023) Vol. 55, Iss. 1
Open Access | Times Cited: 8
Treatment of refractory/relapsed Diamond–Blackfan anaemia with eltrombopag
Brynn B. Duncan, Jennifer L. Lotter, Jeanine Superata, et al.
British Journal of Haematology (2024) Vol. 204, Iss. 5, pp. 2077-2085
Open Access | Times Cited: 2
Studies of a mosaic patient with DBA and chimeric mice reveal erythroid cell–extrinsic contributions to erythropoiesis
Raymond T. Doty, Xing Fan, David J. Young, et al.
Blood (2022) Vol. 139, Iss. 23, pp. 3439-3449
Open Access | Times Cited: 11
Long‐term eltrombopag for bone marrow failure depletes iron
David J. Young, Xing Fan, Emma M. Groarke, et al.
American Journal of Hematology (2022) Vol. 97, Iss. 6, pp. 791-801
Open Access | Times Cited: 10
Comparison of eltrombopag and avatrombopag in the treatment of refractory/relapsed aplastic anemia: a single-center retrospective study in China
Zhuxin Zhang, Qinglin Hu, Chen Yang, et al.
Therapeutic Advances in Hematology (2023) Vol. 14
Open Access | Times Cited: 6
Eltrombopag promotes DNA repair in human hematopoietic stem and progenitor cells
Kacey L. Guenther, Patali S. Cheruku, Ayla Cash, et al.
Experimental Hematology (2019) Vol. 73, pp. 1-6.e6
Open Access | Times Cited: 17
Eltrombopag Improves Erythroid Differentiation in a Human Induced Pluripotent Stem Cell Model of Diamond Blackfan Anemia
Husam Qanash, Yongqin Li, Richard H. Smith, et al.
Cells (2021) Vol. 10, Iss. 4, pp. 734-734
Open Access | Times Cited: 12
Cell senescence and malignant transformation in the inherited bone marrow failure syndromes: Overlapping pathophysiology with therapeutic implications
Emma M. Groarke, Rodrigo T. Calado, Johnson M. Liu
Seminars in Hematology (2022) Vol. 59, Iss. 1, pp. 30-37
Open Access | Times Cited: 7
Adjunctive effects of eltrombopag on immunosuppressive therapy for childhood aplastic anemia
Katsuhide Eguchi, Masataka Ishimura, Shouichi Ohga, et al.
International Journal of Hematology (2024)
Closed Access | Times Cited: 1
Use of Cyclosporine A and danazol in treatment of aplastic anemia: A real-world data from a teaching hospital in South India
Girish Kamat, Renukaradhya K. Math, Deepak Goni, et al.
Asian Journal of Medical Sciences (2022) Vol. 13, Iss. 10, pp. 223-226
Open Access | Times Cited: 4
Comparisons Between Frontline Therapy and a Combination of Eltrombopag Plus Immunosuppression Therapy and Human Leukocyte Antigen-Haploidentical Hematopoietic Stem Cell Transplantation in Patients With Severe Aplastic Anemia: A Systematic Review
Yuan Yang, Ji Jiang, Zengwei Tang, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 5
Atypical Outcomes for Hepatitis-associated Acquired Aplastic Anemia: 2 Case Studies and Review of the Literature
Jillian Lapinski, Deirdre Nolfi‐Donegan, James Cooper, et al.
Journal of Pediatric Hematology/Oncology (2020) Vol. 43, Iss. 5, pp. 195-199
Closed Access | Times Cited: 3
Cyclosporine plus eltrombopag in the treatment of aplastic anemia with or without antithymocyte immunoglobulin: A multicenter real‐world retrospective study
Miao Chen, Qingchi Liu, Yan Gao, et al.
European Journal Of Haematology (2023) Vol. 111, Iss. 3, pp. 407-413
Closed Access | Times Cited: 1
A De Novo Frameshift Mutation in RPL5 with Classical Phenotype Abnormalities and Worsening Anemia Diagnosed in a Young Adult—A Case Report and Review of the Literature
Moritz Dorenkamp, Naomi Porret, Miriam Diepold, et al.
Medicina (2023) Vol. 59, Iss. 11, pp. 1953-1953
Open Access | Times Cited: 1
Long-Term Follow-Up of Eltrombopag Treatment for Patients with Cyclosporin A Refractory/Relapsed Transfusion-Dependent Non-Severe Aplastic Anemia: A Report from a Single Center in China
Qinglin Hu, Yuan Yang, Chen Yang, et al.
Acta Haematologica (2024), pp. 1-10
Open Access
A Systematic Review and Meta-Analysis of Eltrombopag Efficacy Combined With Immunosuppressive Drugs in Treatment of Severe Aplastic Anemia
Janan Illango, Kofi D Seffah, Namballa Naveen, et al.
Cureus (2024)
Open Access
Page 1 - Next Page

Scroll to top